DrGuido represents an innovative Mobile App that allows every consumer to interact with an AI-based Doctor trained for empathetic relationships. Through the mobile app, a patient can query the doctor (using a graphical configurator) and interact with them to obtain a pre-diagnosis, a second opinion on a diagnosis, or ask for information about a prescribed medication. The mobile app also enables sharing the pre-diagnosis with the primary care physician, purchasing over-the-counter medications and supplements from online pharmacies, and contacting a specialist to schedule an appointment. All while ensuring maximum privacy and compliance with AIAct.

In the first year, 80% focus on Italy with testing in countries like Brazil and others in the East Europe. Following years, expansion into Europe and worldwide.

Mobile App exclusively B2C Backend B2B towards partners such as pharmaceutical companies Evolution to B2B towards primary care physicians (supporting their relationship with clients using the app)

Over 20 years of experience in Digital & mobile marketing. The entire business plan is structured on conversion rate metrics between investment in acquisition > interest with app install > engagement with premium app activation (€4.97 per month).

First year with Pre-Seed Round funds: acquisition of the Italian market and validation of conversion rate metrics in the business plan.

• One of the first Generative AI apps for B2C (consumer)
• Specialization in training AI to be empathetic with patients
• Verticalization of services to make them accessible even to inexperienced users (mobile app)
• Established experience of the founders in Mobile Marketing. Guarantee of achieving business metrics

https://heydoc.co.in/
https://symptomate.com/
https://tonicapp.pt/
https://www.medaihealth.com/
https://radailabs.com/
https://docus.ai/

Mission: To enhance accessibility and comprehension of healthcare information through artificial intelligence, offering an intuitive and multilingual service for pre-diagnosis and healthcare consultations. We are committed to being a reliable ally in personal health management, combining advanced technology with an empathetic approach.

Vision: To be a pioneer in transforming the healthcare sector through artificial intelligence, making personal healthcare more accessible, personalized, and intuitive. We aspire to become a global reference point for those seeking innovative digital healthcare, leveraging technology for human well-being.

Investing in Dr.Guido means actively participating in the revolution of the digital healthcare sector. Our unique combination of advanced AI technologies and a user-centered approach provides an unprecedented opportunity to positively influence global healthcare while offering significant financial growth potential. Join us in building a future where access to medical care is more intuitive, personalized, and accessible for everyone.

DrGuido's pre-money valuation has been established considering several key factors. Firstly, the market potential is vast as we target a global market with a pronounced shortage of medical resources. With the growing doctor-to-population ratio, particularly in developing countries, our AI solution has the potential to reach a wide audience, mitigating health access shortages and contributing to improving quality of life.

Additionally, we also considered industry benchmarks. Valuations of AI startups have shown significant trends, with valuations ranging from 1 to over 4 billion dollars for companies with innovative technologies and broad markets.

The pre-money valuation reflects DrGuido's growth potential and its competitive position in the healthcare artificial intelligence market.

The exit strategy is a crucial aspect of our planning. Currently, we are exploring various exit opportunities available for DrGuido, taking into account our progress and growth metrics.

We anticipate that with the planned investments for DrGuido in the coming years, the post-money value of the startup could reach approximately €40/50 million within the fifth year. This post money valuation could attract potential buyers or strategic partners interested in acquiring a startup in the healthcare sector like DrGuido.

The types of companies that might be interested in acquiring DrGuido include large pharmaceutical and healthcare corporations, technology and data analytics companies, and health insurance companies. These companies are always looking for innovative technologies to enhance their services and expand their offerings in the digital health sector.

However, it's important to note that the exit strategy will depend on multiple factors, including market context, partnership opportunities, and economic conditions. We are closely monitoring the market and will adopt the most advantageous exit strategy for our investors.

Like any investment, there are risks to consider in DrGuido's Pre-Seed round. It's important to be aware of these risks before making an investment decision. Some of the key risks may include:

Market risk: The digital health sector is constantly evolving and can be influenced by external factors such as regulatory changes, competition, or economic fluctuations. These factors could impact the growth and success of DrGuido.

Technology risk: Despite our efforts to develop a solid and accurate AI platform, there are always risks associated with technology. Errors or malfunctions could occur that may affect the quality of the service offered by DrGuido.

Adoption risk: The adoption of new technologies in the healthcare sector may take time and encounter resistance from medical professionals or patients. There may be challenges in convincing users to use the DrGuido app and embrace our solution.

Funding risk: Despite our efforts to raise funds, there may be a challenge in securing future funding to support DrGuido's growth. This could impact our ability to achieve development goals and generate a return on investment.

Competition: heavily funded teams of competitors which can copy our busines

It's important to note that we are actively working to mitigate these risks and have a solid plan to address them. We have an experienced team and a well-defined business strategy to maximize opportunities and minimize risks.

Before making an investment decision, we recommend carefully reviewing our investment prospectus and consulting with a financial advisor to assess your personal situation.

DrGuido represents a true breakthrough in digital healthcare. Our AI-driven platform seamlessly integrates cutting-edge artificial intelligence with a humanized interface to deliver precise pre-diagnosis and healthcare consultations. This distinctive approach enhances the quality of healthcare delivery and opens new frontiers in accessibility and understanding within the healthcare field.

Furthermore, we boast a team of highly skilled and passionate experts dedicated to realizing our vision. With professionals possessing complementary expertise in AI, medicine, and software development, we have the capabilities to develop a robust platform and provide high-quality support to our users.

In terms of growth opportunities, the digital healthcare sector is experiencing rapid expansion with vast potential. With our pre-money valuation of €4.4 million and a projected growth trajectory reaching €40/50 million within five years, your investment holds significant potential for substantial returns.

Investing in DrGuido means becoming part of a larger mission. We are committed to radically improving access to healthcare and optimizing the patient experience. Your investment will not only yield financial returns but also actively contribute to meaningful change in the digital healthcare landscape.